Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil

Journal of Clinical Psychopharmacology

Volumn 18, Issue 3, 1998, Pages 241-247

  Smolnik, Rüdiger ^a   Pietrowsky, Reinhard ^b   Fehm, Horst Lorenz ^b   Born, Jan ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CORTICOTROPIN; FLUMAZENIL;

ADULT; ANXIETY; ARTICLE; BEHAVIOR; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG EFFECT; EVENT RELATED POTENTIAL; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SELECTIVE ATTENTION; SYSTOLIC BLOOD PRESSURE;

ADRENOCORTICOTROPIC HORMONE; ADULT; AFFECT; ATTENTION; BLOOD PRESSURE; EVOKED POTENTIALS, AUDITORY; FLUMAZENIL; GABA MODULATORS; HEART RATE; HUMANS; HYDROCORTISONE; MALE;

EID: 0031802924     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199806000-00010     Document Type: Article

References (33)

1. Brogden RN, Goa KL. Flumazenil: a preliminary review of its benzodiazepine antagonist properties, intrinsic activity and therapeutic use. Drugs 1988;35:448-67.
2. Mandema JW, Gubbens-Stibbe JM, Danhof M. Stability and pharmacokinetics of flumazenil in the rat. Psychopharmacology 1991; 103:384-7.
3. Mandema JW, Tukker E, Danhof M. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil. J Pharmacol Exp Ther 1992;260:36-44.
4. Danhof M, Mandema JW. Modelling of the pharmacodynamics and pharmacodynamic interactions of CNS active drugs. Int J Clin Pharmacol Ther Toxicol 1992;30:516-9.
5. Mandema JW, Kuck MT, Danhof M. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship. Br J Pharmacol 1992;105:164-70.
6. Pellow S, File SE. Multiple sites of action for anxiogenic drugs: behavioral, electrophysiological and biochemical correlations. Psychopharmacology 1984;83:304-15.
7. File SE, Pellow S. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology 1986;88:1-11.
8. Kochs E, Wüst P, Blanc I, Schulte am Esch J. Akustisch und somatosensorisch evozierte kortikale Potentiale unter Sedierung mit Midazolam und Antagonisierung durch Flumazenil. Anästh Intensivther Notfallmed 1989;24:49-56.
9. Gottschalk D, Tolksdorf W, Debus G, Fröhlich J. Die Vigilanz nach sedierenden Dosen Midazolam und Antagonisierung mit Flumazenil unter Verwendung zweier Aufmerksamkeitsparadigmen. In: Tolksdorf W (Hrsg). Sedierung und Analgesie bei diagnostischen Eingriffen. Basel, Switzerland: Editiones Roche, 1990:39-57.
10. Hillyard SA, Hink RF, Schwent VL, Picton TW. Electrical signs of selective attention in the human brain. Science 1973;182:177-80.
11. Näätänen R. The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav Brain Sci 1990;13: 201-88.
12. Shelley AM, Catts SV, Ward PB, Michie PT, Andrews S, Mitchell PF, McConaghy N. The effects of morphine and naloxone on auditory ERPs. In: Brunia CHM, Gaillard AWK, Kok A, eds. Psychophysiological brain research. Vol. 2. Le Tilburg, The Netherlands: Tilburg University Press, 1990:120-5.
13. Arnsten AFT, Segal DS, Neville HJ, Hillyard SA, Janowsky DS, Judd LL, Bloom FE. Naloxone augments electrophysiological signs of selective attention in man. Nature 1983;304:725-7.
14. Born J, Bräuninger W, Fehm-Wolfsdorf G, Voigt KH, Pauschinger P, Fehm HL. Dose-dependent influences on electrophysiological signs of attention in humans after neuropeptide ACTH 4-10. Exp Brain Res 1987;67:85-92.
15. Hink RF, Fenton WH Jr, Tinklenberg JR, Pfefferbaum A, Kopell BS. Vigilance and human attention under conditions of methylphenidate and secobarbital intoxication: an assessment using brain potentials. Psychophysiology 1978;15:116-25.
16. Schreiber H, Stolz-Born G, Pietrowsky R, Kornhuber HH, Fehm HL, Born J. Improved event-related potential signs of selective attention after the administration of the cholecystokinin analog ceruletide in healthy persons. Biol Psychiatry 1995;37:702-12.
17. Janke W, Debus G. Die Eigenschaftswörterliste. EWL. Göttingen, Germany: Hogrefe, 1978.
18. Laux L, Glanzmann P, Schaffner P, Spielberger CD. State-Trait-Angstinventar (STAI). Weinheim, Germany: Beltz Testgesellschaft, 1981.
19. Sugarman JM, Paul RI. Flumazenil: a review. Pediatr Emerg Care 1994;10:37-43.
20. Brickenkamp R. Test d2. Aufmerksamkeits-Belastungs-Test Göttingen, Germany: Hogrefe, 1981.
21. Dixon WJ. BMDP Statistical Software Manual, Vol. 1-3. Berkeley, CA: University of California Press, 1992.
22. Higgitt A, Lader M, Fonagy P. The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects. Psychopharmacology 1986;89:395-403.
23. Näätänen R. Selective attention and stimulus processing: reflections in event-related potentials, magnetoencephalogram and regional cerebral blood flow. In: Posner MI, Marin OS, eds. Attention and performance XI; Hillsdale, NJ: Erlbaum, 1985;355-73.
24. Darragh A, Lambe R, O'Boyle C, Kenny M, Brick I. Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788. Psychopharmacology 1983;80:192-5.
25. Donchin E, Coles MGH. Is the P300 component a manifestation of context updating? Behav Brain Sci 1988;11:357-74.
26. Verleger R. Event-related potentials and cognition: a critique of the context updating hypothesis and an alternative interpretation of the P3. Behav Brain Sci 1988;11:343-56.
27. Woldorff MG, Hackley SA, Hillyard SA. The effects of channel-selective attention on the mismatch negativity wave elicited by deviant tones. Psychophysiology 1991;28:30-42.
28. Oades RD, Dittmann-Balcar A. Mismatch negativity (MMN) is altered by directing attention. Neuroreport 1995;6:1187-90.
29. Schöpf J, Laurian S, Le PK, Gaillard JM. Intrinsic activity of the benzodiazepine antagonist Ro 15-1788 in man: an electrophysiological investigation. Pharmacopsychiatry 1984;17:79-83.
30. Pietrowsky R, Rudolf S, Mölle M, Fehm HL, Born J. Cholecystokinin-induced effects on selective attention depend on level of activation. Neuropsychobiology 1997;36:87-95.
31. Preston GC, Ward CE, Broks P, Traub M, Stahl SM. Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788. Psychopharmacology 1989;97:222-7.
32. Kozená L, Frantik E, Horváth M. Vigilance impairment after a single dose of benzodiazepines. Psychopharmacology 1995;119:39-46.
33. Preston GC, Broks P, Traub M, Ward C, Poppleton P, Stahl SM. Effects of lorazepam on memory, attention and sedation in man. Psychopharmacology 1988;95:208-15.